The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Net Income

Bottom-line profit, the starting point for calculating cash from operations.

The Oncology Institute, Inc.NASDAQ: TOI

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income declines year over year

Q1 FY2026 net income of $2.49M (cash outflow) fell 87.3% year over year, ahead of the -93.1% change in trailing-twelve-month net income.

Context

  • Net income amounted to 12.1% of revenue in FY2025, down 1.4 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of -$138.58M (+128.7%) for the fiscal year ending Dec 2026, a step up from the +14.3% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.49M-108.7% QoQ
Last fiscal yearDec 2025
-$60.61M+14.3% YoY
LTMMar 2026
-$4.27M-93.1% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-87.3%+333.7%+421.0 pp
1 year+14.3%+128.7%+114.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(60.61M) USD
Year-over-year change
-14.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -93.1% is the lowest of 10, against a peer median of +21.3%.
  • Net income amounts to 0.8% of revenue for TOI, versus a peer median of 16.3%.
TOI Competitors
Net Income for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$354.54M USD+41.1%+54.1%6.1%
AUTLAutolus Therapeutics plcLTM Mar 2026$288.97M USD+21.3%+24.5%312.1%
SNDASonida Senior Living, Inc.LTM Mar 2026$100.48M USD+131.9%+10.0%24.4%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$98.63M USD+456.0%—9.8%
AUNAAuna S.A.LTM Mar 2026PEN 78.03M PEN-54.2%—1.7%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$61.04M USD+15.2%+11.3%29.4%
CBLLCeriBell, Inc.LTM Mar 2026$60.37M USD+35.0%+12.9%63.5%
EOLSEvolus, Inc.LTM Mar 2026$43.42M USD-22.7%-11.5%14.4%
KIDSOrthoPediatrics Corp.LTM Mar 2026$39.68M USD-2.5%—16.3%
TOIThe Oncology Institute, Inc.LTM Mar 2026$4.27M USD-93.1%—0.8%
Peer median (excluding TOI) —+21.3%+12.1%16.3%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.93M)152K(83.07M)(53.01M)(60.61M)
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
Deferred Income Tax(1.24M)(263K)(76K)0(32K)
Stock-Based Compensation24.54M27.68M17.81M11.15M4.55M
Change in Working Capital(14.49M)(20.54M)2.36M18.06M1.33M
Accounts Receivables(2.99M)(19.67M)(4.5M)(5.77M)(12.58M)
Inventory(1.84M)(1.73M)(4.39M)3.64M(6.84M)
Accounts Payables2.92M(6.19M)5.06M9.22M19.64M
Other Working Capital(12.58M)7.04M6.19M10.98M1.11M
Other Non-Cash Items(33.9M)(73.2M)20.79M2.12M23.23M
Operating Cash Flow(32.68M)(61.76M)(36.32M)(26.54M)(24.59M)
Capital Expenditures(3.05M)(5.53M)(4.57M)(3.79M)(3.2M)
Acquisitions (Net)(9.11M)(8.58M)(4.46M)00
Purchases of Investments0(117.51M)(9.6M)00
Sales of Investments0081.26M50M126K
Other Investing Activities(200K)0000
Investing Cash Flow(12.15M)(131.61M)62.64M46.21M(3.07M)
Debt Repayment(7.25M)109.94M(101K)(39K)(20.04M)
Common Stock Issued00075K32.63M
Common Stock Repurchased0(9M)(1.02M)00
Dividends Paid00000
Other Financing Activities141.26M(8.74M)(5.73M)(3.53M)(1.04M)
Financing Cash Flow154.01M92.21M(6.85M)(3.49M)11.56M
Effect of Forex Changes00000
Net Change in Cash109.18M(101.16M)19.48M16.18M(16.1M)
Free Cash Flow(35.73M)(67.29M)(40.88M)(30.33M)(27.79M)

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.